Patents matching “inhibitor”

US 6270781

Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

Maxim Pharmaceuticals, Inc. · Granted Aug 7, 2001 · Expires Aug 2, 2021

US 6265380

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

Vertex Pharmaceuticals Incorporated · Granted Jul 24, 2001 · Expires Jul 19, 2021

US 6265160

Method of identifying inhibitors of the Jak-Stat signal transduction pathway

The United States of America, as represented by the Department of Health and Human Services · Granted Jul 24, 2001 · Expires Jul 19, 2021

US 6262047

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Jul 17, 2001 · Expires Jul 12, 2021

US 6262069

1-amino-7-isoquinoline derivatives as serine protease inhibitors

Protherics Molecular Design Ltd. · Granted Jul 17, 2001 · Expires Jul 12, 2021

US 6258948

Inhibitors of Interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2001 · Expires Jul 5, 2021

US 6255091

Potentiating metal mediated serine protease inhibitors with cobalt or zinc ions

The Regents of the University of California · Granted Jul 3, 2001 · Expires Jun 28, 2021

US 6255485

Purine inhibitors of protein kinases, G proteins and polymerases

The Regents of the University of California · Granted Jul 3, 2001 · Expires Jun 28, 2021

US 6248749

Use of inhibitors of the activity of retinoic acid for treating sensit ive skin and/or acute damage induced by UV radiation

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Jun 19, 2001 · Expires Jun 14, 2021

US 6245743

Inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Jun 12, 2001 · Expires Jun 7, 2021

US 6245563

Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitor

Maxim Pharmaceuticals, Inc. · Granted Jun 12, 2001 · Expires Jun 7, 2021

US 6228854

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted May 8, 2001 · Expires May 3, 2021

US 6225292

Inhibitors of DNA immunostimulatory sequence activity

The Regents of the University of California · Granted May 1, 2001 · Expires Apr 26, 2021

US 6221877

Substituted 4-phthalimidocarboxanilides as inhibitors of purine salvage phosphoribosyltransferases

The Regents of the University of California · Granted Apr 24, 2001 · Expires Apr 19, 2021

AU 7286300

Dispersion formulations containing lipase inhibitors

CHEPLAPHARM ARZNEIMITTEL GMBH · Granted Apr 17, 2001 · Expires Apr 12, 2021

US 6218382

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Apr 17, 2001 · Expires Apr 12, 2021

US 6211154

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Apr 3, 2001 · Expires Mar 29, 2021

US 6211183

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Apr 3, 2001 · Expires Mar 29, 2021

US 6211149

Inhibitors of formation of protease resistant prion protein

The United States of America, as represented by the Department of Health and Human Services · Granted Apr 3, 2001 · Expires Mar 29, 2021

US 6204268

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Mar 20, 2001 · Expires Mar 15, 2021

US 6204261

Inhibitors of interleukin-1.beta. Converting enzyme inhibitors

Vertex Pharmaceuticals Incorporated · Granted Mar 20, 2001 · Expires Mar 15, 2021

US 6197748

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Mar 6, 2001 · Expires Mar 1, 2021

US 6197811

Cytokine production inhibitors

TerraGen Discovery Inc. · Granted Mar 6, 2001 · Expires Mar 1, 2021

US 6194421

Inhibitors of metazoan parasite proteases

The Regents of the University of California · Granted Feb 27, 2001 · Expires Feb 22, 2021